Balyasny Asset Management
ROIVW

Balyasny Asset Management’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Balyasny Asset Management’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-150,000
Closed -$59K – 3369
2022
Q3 		$59K Hold
150,000
– – ﹤0.01% 2458
2022
Q2 		$90K Hold
150,000
– – ﹤0.01% 2293
2022
Q1 		$132K Hold
150,000
– – ﹤0.01% 2101
2021
Q4 		$305K Buy
+150,000
New +$229K ﹤0.01% 1739

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Balyasny Asset Management's ROIVW Position: Q4 2022 in Review

Balyasny Asset Management sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q4 2022, closing a stake of 150,000 shares — an estimated $59K sold.

Balyasny Asset Management first reported a position in ROIVW in Q4 2021 and held it in 4 quarters. The position peaked at $305K in Q4 2021. 28 funds tracked by Wall St. Rank hold ROIVW as of Q4 2022.

  • Balyasny Asset Management reported no remaining Roivant Sciences Ltd. Warrant position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 150,000 Roivant Sciences Ltd. Warrant shares in Q4 2022, an estimated $59K.
  • Balyasny Asset Management first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 4 quarters.
  • Balyasny Asset Management's Roivant Sciences Ltd. Warrant position peaked at $305K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.